FDA
- Status: approved
🇺🇸 Prednisone 2 in United States
3 US adverse-event reports
Marketing authorisation
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 20 April 2025 – 20 April 2026
- Total reports: 3
Most-reported reactions
- Adrenal Disorder — 1 report (33.33%)
- Drug Dependence — 1 report (33.33%)
- Pain — 1 report (33.33%)
Prednisone 2 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Prednisone 2 approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Prednisone 2 in United States?
Polish Lymphoma Research Group is the originator. The local marketing authorisation holder may differ — check the official source linked above.